Pictet & Cie (Europe) Sa Vertex Pharmaceuticals Inc Transaction History

Pictet & Cie (Europe) Sa

$4.19 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$392.81 - $485.53 $116,271 - $143,716	-296 Reduced 28.52%	742 $347,000
Q1 2024 May 07, 2024	SELL	$407.69 - $446.08 $28,130 - $30,779	-69 Reduced 6.23%	1,038 $433,000
Q4 2023 Feb 09, 2024	SELL	$343.0 - $410.68 $14,406 - $17,248	-42 Reduced 3.66%	1,107 $450,000
Q3 2023 Nov 02, 2023	SELL	$338.18 - $362.46 $5,072 - $5,436	-15 Reduced 1.29%	1,149 $399,000
Q2 2023 Aug 08, 2023	SELL	$314.42 - $351.91 $364,412 - $407,863	-1,159 Reduced 49.89%	1,164 $409,000
Q1 2023 May 01, 2023	BUY	$283.23 - $323.1 $125,187 - $142,810	442 Added 23.5%	2,323 $731,000
Q4 2022 Feb 08, 2023	SELL	$285.76 - $321.48 $207,461 - $233,394	-726 Reduced 27.85%	1,881 $0
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $164,024 - $183,012	-599 Reduced 18.68%	2,607 $755 Million
Q2 2022 Aug 05, 2022	SELL	$234.96 - $292.55 $406,950 - $506,696	-1,732 Reduced 35.07%	3,206 $903,000
Q1 2022 May 04, 2022	SELL	$221.42 - $260.97 $2.95 Million - $3.47 Million	-13,304 Reduced 72.93%	4,938 $1.29 Million
Q4 2021 Feb 02, 2022	SELL	$177.01 - $223.45 $98,240 - $124,014	-555 Reduced 2.95%	18,242 $4.01 Million
Q3 2021 Nov 10, 2021	SELL	$181.39 - $202.99 $6.2 Million - $6.93 Million	-34,154 Reduced 64.5%	18,797 $3.41 Million
Q2 2021 Aug 11, 2021	BUY	$187.49 - $221.1 $6.85 Million - $8.08 Million	36,560 Added 223.05%	52,951 $10.7 Million
Q1 2021 May 10, 2021	SELL	$207.02 - $241.31 $10.8 Million - $12.6 Million	-52,409 Reduced 76.18%	16,391 $3.52 Million
Q4 2020 Feb 11, 2021	BUY	$207.01 - $276.09 $3.86 Million - $5.15 Million	18,641 Added 37.16%	68,800 $16.3 Million
Q3 2020 Nov 10, 2020	BUY	$255.65 - $303.1 $12.8 Million - $15.2 Million	50,159 New	50,159 $13.6 Million
Q1 2019 May 01, 2019	SELL	$163.73 - $194.7 $687,666 - $817,740	-4,200 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$151.91 - $192.21 $638,022 - $807,282	4,200 New	4,200 $696,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.5 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.8 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.9 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.49 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.18 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.

Account